US20050006255A1 - Contact lens packages containing additives - Google Patents
Contact lens packages containing additives Download PDFInfo
- Publication number
- US20050006255A1 US20050006255A1 US10/731,258 US73125803A US2005006255A1 US 20050006255 A1 US20050006255 A1 US 20050006255A1 US 73125803 A US73125803 A US 73125803A US 2005006255 A1 US2005006255 A1 US 2005006255A1
- Authority
- US
- United States
- Prior art keywords
- package
- pvp
- concentration
- average roughness
- maleic anhydride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45C—PURSES; LUGGAGE; HAND CARRIED BAGS
- A45C11/00—Receptacles for purposes not provided for in groups A45C1/00-A45C9/00
- A45C11/005—Contact lens cases
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45C—PURSES; LUGGAGE; HAND CARRIED BAGS
- A45C11/00—Receptacles for purposes not provided for in groups A45C1/00-A45C9/00
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45C—PURSES; LUGGAGE; HAND CARRIED BAGS
- A45C11/00—Receptacles for purposes not provided for in groups A45C1/00-A45C9/00
- A45C11/04—Spectacle cases; Pince-nez cases
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45C—PURSES; LUGGAGE; HAND CARRIED BAGS
- A45C11/00—Receptacles for purposes not provided for in groups A45C1/00-A45C9/00
- A45C11/04—Spectacle cases; Pince-nez cases
- A45C11/046—Spectacle cases; Pince-nez cases with contact lens holders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/086—Container, accessories or devices therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B25/00—Packaging other articles presenting special problems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B25/00—Packaging other articles presenting special problems
- B65B25/008—Packaging other articles presenting special problems packaging of contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
- B65B55/22—Immersing contents in protective liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
Definitions
- This invention related to packages for storing contact lenses as well as methods of using and preparing these packages.
- FIG. 1 illustrates the data for Lens A in different packages
- FIG. 2 illustrates the data for Lens B in different packages
- FIG. 3 illustrates the data for Lens C in different packages
- This invention includes a package for storing medical devices in a solution comprising, consisting essentially of, or consisting of, a molded base wherein the molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema.
- a “medical device” is any device that is stored or packaged in a solution and is used to treat a human disease.
- medical devices include but are not limited to ophthalmic devices that reside in or on the eye.
- Ophthalmic devices includes but are not limited to soft contact lenses, intraocular lenses, overlay lenses, ocular inserts, and optical inserts. These devices can provide optical correction or may be cosmetic.
- the preferred medical devices of the invention are soft contact lenses made from silicone elastomers or hydrogels, which include but are not limited to silicone hydrogels, and fluorohydrogels.
- Soft contact lens formulations are disclosed in U.S.
- the particularly preferred medical devices of the invention are soft contact lenses made from etafilcon A, genfilcon A, lenefilcon A, polymacon, balafilcon A, lotrafilcon A. and silicone hydrogels as prepared in U.S. Pat. No. 5,998,498, U.S. patent application Ser. No. 09/532,943, a continuation-in-part of U.S. patent application Ser. No. 09/532,943, filed on Aug. 30, 2000, U.S. Pat. No. 6,087,415, U.S. Pat. No. 5,760,100, U.S. Pat. No. 5,776, 999, U.S. Pat. No. 5,789,461, U.S. Pat. No.
- the more particularly preferred medical devices of the invention are soft contact lenses, balafilcon A, lotrafilcon A, galyfilcon A, senofilcon A, or those made as described in U.S. patent application Ser. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on Sep. 10, 2001 and its non-provisional counterpart of the same title, filed on Sep. 6, 2002.
- the most particularly preferred medical devices are soft contact lenses made from either galyfilcon A or senofilcon A.
- molded base refers to any polymer, rubber, or plastic that can be formed into a receptacle for medical devices, where the size and shape of the base are determined by the device and other considerations known those who are skilled in the art of making or designing molded bases.
- molded bases may be individual blister packages, secondary packages, or hydrating trays.
- the molded base may be prepared from any number of materials provided that those materials are compatible with the chemical and physical properties of the device. Examples of suitable materials include but are not limited to polypropylene, polyethylene, nylons, olefin co-polymers, acrylics, rubbers, urethanes, polycarbonates, or fluorocarbons.
- the preferred materials are metallocenes polymers and co-polymers made of polypropylene, polyethylene, having a melt flow range of about 15 g/10 minutes to about 44 g/10 minutes as determined by ASTM D-1238.
- examples of suitably shaped bases are disclosed in the following patents which are hereby incorporated by reference in their entirety, U.S. Pat. Nos.
- Flexible cover sheets can be made from can be an adhesive laminate of an aluminum foil and a polypropylene film or any other extruded or co-extruded film that can be sealed to the top surface of the flange in order to form a hermetic seal for the medical device and the solution.
- the base can be formed by any of a number of known methods which include but are not limited to injection molding, transfer molding, skin packaging, blow molding, coinjection molding, film extrusion, or film co-extrusion.
- additive refers to a substance that is added to the polymer, rubber, or plastic prior to forming the molded base, where the material inhibits sticking, adherence, or adhesion of the medical device to the molded base.
- the additive is mixed with the remainder of the molded base material and amount of additive present by weight percentage based on the total weight of the molded base material is greater than about 0.25 to about 10 weight percent, preferably greater than about 0.25 to about 5 weight percent, most preferably about 0.25 to about 3 weight percent.
- the preferred additives are glycerol monostearate (2%), polyvinylpyrolidone (1% to 5%), polyvinylpyrolidone/maleic anhydride (1/1% to 5/5%), and succinic acid (5%).
- Polyvinylpyrolidinone has a variety of molecular weight ranges (as indicated by the KD#) and consistencies (flake, powdered/micronized). When PVP KD90 is used as an additive, it is preferred that it is powered/micronized.
- solution refers to any liquid medium in which a medical device is stored.
- the preferred solutions are aqueous solutions contain physiological buffers.
- the particularly preferred solution is saline solution.
- the medical device is a contact lens
- the molded base is transparent to the degree necessary to permit visual inspection, UV sterilization or both.
- the preferred additives are glycerol monostearate present at about 2 weight percent, succininc acid present at about 5 weight percent, PVP KD90 present at about 1-5 weight percent, PVP/maleic anhydride present at about 1/1 to about 5/5 weight percent. If the inner surface of the medical device has a roughness of about 0.2 ⁇ m to about 4.5 ⁇ m, the preferred additives are maleic anhydride or PVP/maleic anhydride, most preferably maleic anhydride.
- the invention includes a method of reducing the adherence of a medical device to its packaging, comprising, consisting essentially of, or consisting of, storing said medical device in a solution in a package comprising, consisting essentially of, or consisting of, a molded base wherein said molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema.
- molded base, medical device, solution and additive all have their aforementioned meanings and preferred ranges.
- soft contact lenses When soft contact lenses are prepared, the lenses cured to a hard disc and subsequently hydrated with water to give the non-sterilized final product. During this hydration step, soft contact lenses often stick to the surface of the hydration chamber and it would useful to find a method of hydrating soft contact lenses which alleviates this problem.
- the invention includes a method of hydrating a contact lens comprising, consisting essentially of, or consisting of hydrating said lens in a molded base wherein said molded base comprises an additive.
- molded base, medical device, solution and additive all have their aforementioned meanings.
- the preferred values for the medical device, the solution and the additive are as listed above.
- the preferred molded base is a square or a rectangle.
- Ampacet 40604 fatty acid amide ATOFINA Finacene Nucleated polypropylene having a melt 3924CWZ flow of 55 g/10 minutes, ASTM D1238.
- This material contains an antistat and a lubricant Atmer 163 fatty alkyl diethanolamine Reg. No. 107043-84-5 Dow Siloxane a silicone dispersion MB50-321 Epolene E43-Wax, maleic anhydride produced by Eastman Chemical Erucamide fatty acid amide Registry No.
- Lens C Contact lenses prepared as described in U.S. Pat. App. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on September 10, 2001 and its non-provisional counterpart of the same title, filed on September 6, 2002, containing by weight percent 28% Simma 2, 31% mPDMS, 23.5% DMA, 7% PVP (MW 360,000), 1.5% TEDGMA, 0.98% CGI 1850, 2.0% Norbloc, 6 HEMA, 0.02% Blue Hema.
- Additives (identity and amounts listed in Table 1) were mixed with polypropylene (listed below).
- the material was injection molded to form the base portion of a contact lens package.
- the configuration of the package is as illustrated in FIG. 1 of U.S. Pat. No. 5,467,868 which is hereby incorporated by reference.
- Packages containing 2% weight percent GMS and Exxon 1605 were prepared using the method of Example 1. Contact lenses of types A, B, and C were added to individual blister packages along with 950 ⁇ L of saline solution. The filed packages were heat sealed with flexible covers and sterilized. The packaged lenses were submitted to consumers. The consumers opened the packages and evaluated the lenses for ease of removal of the lens from the package using the following criteria and grading system
- FIG. 1 illustrates the testing results for a comparison of Lens A in a polypropylene package (control), Lens A in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 ⁇ m, and Len A in a package containing 2.0% GMS. This figure shows that the roughened package containing GMS has the highest consumer rating.
- FIG. 2 illustrates the testing results for a comparison of Lens B in a polypropylene package (control), Lens B in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 am, and Len B in a package containing 2.0% GMS. This figure shows that the package containing 2.0%GMS has the highest consumer rating.
- FIG. 3 illustrates the testing results for a comparison of Lens C in a polypropylene package (control), Lens C in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 ⁇ m, and Len C in a package containing 2.0% GMS. This figure shows that the package containing 2.0% GMS has the highest consumer rating.
- Example 1 The testing methods and preparations of Example 1 were repeated with different additives and lens types as per Table 2. If “(UP)” appears in an entry, that bowl of the blister is shaped as in U.S. Pat. No. D 458,023. When the term “Rough Bowl” appears, the inside surface of the bowl is roughened to an Ra of 0.5 mm to 0.8 mm.
Abstract
A package having an additive that does not adhere to a medical device enclosed therein.
Description
- This application is a non-provisional filing of a provisional application, U.S. patent application Ser. No. 60/436,109, filed on Dec. 23, 2002.
- This invention related to packages for storing contact lenses as well as methods of using and preparing these packages.
- Contact lenses have been used commercially to improve vision since the 1950s. At first contact lenses were made of hard materials, which were relatively easy to handle and package for use, but were uncomfortable for many patients. Later developments, gave rise to softer more comfortable lenses made of hydrophobic hydrogels, particularly silicone hydrogels. These lenses are very pliable, but due to this texture and their chemical composition, they present a number of problems with packaging.
- Most contact lenses are packaged in individual blister packages having a bowl portion and a foil top, where the bowl portion is made from a hydrophobic material such as polypropylene. See U.S. Pat. Nos. 4,691,820; 5,054,610; 5,337,888; 5,375,698; 5,409,104; 5,467,868; 5,515,964; 5,609,246; 5,695,049; 5,697,495; 5,704,468; 5,711,416; 5,722,536; 5,573,108; 5,823,327; 5,704,468; 5,983,608; 6,029,808; 6,044,966; and 6,401,915 for examples of such packaging, all of which are hereby incorporated by reference in their entirety. While polypropylene is resilient enough to withstand the sterilization steps of contact lens manufacture, this material has an affinity for contact lenses made of silicone hydrogels. When silicone hydrogels are packaged in polypropylene bowls, the lenses stick to the bowl and cannot be removed from the package without damaging the pliable lenses. Therefore is a need to prepare a contact lens package that has resilient properties, but does not stick to the final product. It is this need that is met by the following invention.
-
FIG. 1 illustrates the data for Lens A in different packages -
FIG. 2 illustrates the data for Lens B in different packages -
FIG. 3 illustrates the data for Lens C in different packages - This invention includes a package for storing medical devices in a solution comprising, consisting essentially of, or consisting of, a molded base wherein the molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema.
- As used herein a “medical device” is any device that is stored or packaged in a solution and is used to treat a human disease. Examples of medical devices include but are not limited to ophthalmic devices that reside in or on the eye. Ophthalmic devices includes but are not limited to soft contact lenses, intraocular lenses, overlay lenses, ocular inserts, and optical inserts. These devices can provide optical correction or may be cosmetic. The preferred medical devices of the invention are soft contact lenses made from silicone elastomers or hydrogels, which include but are not limited to silicone hydrogels, and fluorohydrogels. Soft contact lens formulations are disclosed in U.S. patent application Ser. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on Sep. 10, 2001 and its non-provisional counterpart of the same title, filed on Sep. 6, 2002, U.S. Pat. No. 5,710,302, WO 9421698, EP 406161, JP 2000016905, U.S. Pat. No. 5,998,498, U.S. patent application Ser. No. 09/532,943, U.S. Pat. No. 6,087,415, U.S. Pat. No. 5,760,100, U.S. Pat. No. 5,776, 999, U.S. Pat. No. 5,789,461, U.S. Pat. No. 5,849,811, and U.S. Pat. No. 5,965,631. The foregoing references are hereby incorporated by reference in their entirety. The particularly preferred medical devices of the invention are soft contact lenses made from etafilcon A, genfilcon A, lenefilcon A, polymacon, balafilcon A, lotrafilcon A. and silicone hydrogels as prepared in U.S. Pat. No. 5,998,498, U.S. patent application Ser. No. 09/532,943, a continuation-in-part of U.S. patent application Ser. No. 09/532,943, filed on Aug. 30, 2000, U.S. Pat. No. 6,087,415, U.S. Pat. No. 5,760,100, U.S. Pat. No. 5,776, 999, U.S. Pat. No. 5,789,461, U.S. Pat. No. 5,849,811, and U.S. Pat. No. 5,965,631. These patents as well as all other patent disclosed in this application are hereby incorporated by reference in their entirety. The more particularly preferred medical devices of the invention are soft contact lenses, balafilcon A, lotrafilcon A, galyfilcon A, senofilcon A, or those made as described in U.S. patent application Ser. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on Sep. 10, 2001 and its non-provisional counterpart of the same title, filed on Sep. 6, 2002. The most particularly preferred medical devices are soft contact lenses made from either galyfilcon A or senofilcon A.
- The term “molded base” refers to any polymer, rubber, or plastic that can be formed into a receptacle for medical devices, where the size and shape of the base are determined by the device and other considerations known those who are skilled in the art of making or designing molded bases. For example molded bases may be individual blister packages, secondary packages, or hydrating trays. The molded base may be prepared from any number of materials provided that those materials are compatible with the chemical and physical properties of the device. Examples of suitable materials include but are not limited to polypropylene, polyethylene, nylons, olefin co-polymers, acrylics, rubbers, urethanes, polycarbonates, or fluorocarbons. The preferred materials are metallocenes polymers and co-polymers made of polypropylene, polyethylene, having a melt flow range of about 15 g/10 minutes to about 44 g/10 minutes as determined by ASTM D-1238. With respect to the shape of the molded base, examples of suitably shaped bases are disclosed in the following patents which are hereby incorporated by reference in their entirety, U.S. Pat. Nos. D 458,023; 4,691,820; 5,054,610; 5,337,888; 5,375,698; 5,409,104; 5,467,868; 5,515,964; 5,609,246; 5,695,049; 5,697,495; 5,704,468; 5,711,416; 5,722,536; 5,573,108; 5,823,327; 5,704,468; 5,983,608; 6,029,808; 6,044,966; and 6,401,915. As in the cited references, the molded based is sealed about the cavity that encloses the contact lens. Flexible cover sheets can be made from can be an adhesive laminate of an aluminum foil and a polypropylene film or any other extruded or co-extruded film that can be sealed to the top surface of the flange in order to form a hermetic seal for the medical device and the solution. Further, the base can be formed by any of a number of known methods which include but are not limited to injection molding, transfer molding, skin packaging, blow molding, coinjection molding, film extrusion, or film co-extrusion.
- As used herein the term “additive” refers to a substance that is added to the polymer, rubber, or plastic prior to forming the molded base, where the material inhibits sticking, adherence, or adhesion of the medical device to the molded base. The additive is mixed with the remainder of the molded base material and amount of additive present by weight percentage based on the total weight of the molded base material is greater than about 0.25 to about 10 weight percent, preferably greater than about 0.25 to about 5 weight percent, most preferably about 0.25 to about 3 weight percent. The preferred additives are glycerol monostearate (2%), polyvinylpyrolidone (1% to 5%), polyvinylpyrolidone/maleic anhydride (1/1% to 5/5%), and succinic acid (5%). Polyvinylpyrolidinone has a variety of molecular weight ranges (as indicated by the KD#) and consistencies (flake, powdered/micronized). When PVP KD90 is used as an additive, it is preferred that it is powered/micronized.
- The term “solution” refers to any liquid medium in which a medical device is stored. The preferred solutions are aqueous solutions contain physiological buffers. The particularly preferred solution is saline solution.
- For example, if the medical device is a contact lens, it is preferred that the molded base is transparent to the degree necessary to permit visual inspection, UV sterilization or both. The preferred additives are glycerol monostearate present at about 2 weight percent, succininc acid present at about 5 weight percent, PVP KD90 present at about 1-5 weight percent, PVP/maleic anhydride present at about 1/1 to about 5/5 weight percent. If the inner surface of the medical device has a roughness of about 0.2 μm to about 4.5 μm, the preferred additives are maleic anhydride or PVP/maleic anhydride, most preferably maleic anhydride.
- Further, the invention includes a method of reducing the adherence of a medical device to its packaging, comprising, consisting essentially of, or consisting of, storing said medical device in a solution in a package comprising, consisting essentially of, or consisting of, a molded base wherein said molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema. The terms molded base, medical device, solution and additive all have their aforementioned meanings and preferred ranges.
- When soft contact lenses are prepared, the lenses cured to a hard disc and subsequently hydrated with water to give the non-sterilized final product. During this hydration step, soft contact lenses often stick to the surface of the hydration chamber and it would useful to find a method of hydrating soft contact lenses which alleviates this problem.
- To solve this problem, the invention includes a method of hydrating a contact lens comprising, consisting essentially of, or consisting of hydrating said lens in a molded base wherein said molded base comprises an additive. The terms molded base, medical device, solution and additive all have their aforementioned meanings. The preferred values for the medical device, the solution and the additive are as listed above. The preferred molded base is a square or a rectangle.
- Other have tried to address the problem of a medical device adhering to its packaging. For example U.S. patent application Ser. No. 09/942,347, entitled “Textured Contact Lens Package,” filed on Aug. 29, 2001 and U.S. patent application Ser. No. 10/183,133, entitled “Contact Lens Packages, ” filed on Jun. 26, 2002 disclose solutions to this problem. The disclosure of these applications are hereby incorporated by reference in their entirety. Even though those methods address this problem, it is contemplated by the inventors of this patent application that the additives of this invention may be incorporated into the packaging of each of the cited references.
- In order to illustrate the invention the following examples are included. These examples do not limit the invention. They are meant only to suggest a method of practicing the invention. Those knowledgeable in contact lenses as well as other specialties may find other methods of practicing the invention. However, those methods are deemed to be within the scope of this invention.
- The following abbreviations are used below
Ampacet 40604 fatty acid amide ATOFINA Finacene Nucleated polypropylene having a melt 3924CWZ flow of 55 g/10 minutes, ASTM D1238. This material contains an antistat and a lubricant Atmer 163 fatty alkyl diethanolamine Reg. No. 107043-84-5 Dow Siloxane a silicone dispersion MB50-321 Epolene E43-Wax, maleic anhydride produced by Eastman Chemical Erucamide fatty acid amide Registry No. 112-84-5 Exxon 1605 Exxon Achieve, PP1605, a metallocene polypropylene having a melt flow of 32 g/10 minutes, ASTM D-1238 (L) Exxon 1654 Exxon Achieve, PP1654, a metallocene isotactic polypropylene having a melt flow of 16 g/10 minutes, ASTM D-1238 (L) Fina EOD-001 Finacene, a metallocene and isotactic polypropylene having a melt flow of 16 g/10 minutes, ASTM D1238 Flura Registry No. 7681-49-4 Kemamide fatty acid amide Licowax fatty acid amide Mica Registry No. 12001-26-2 Nurcrel 535 & 932 ethylene-methacrylic acid co-polymer resin Registry No. 25053-53-6 Oleamide fatty acid amide Registry No. 301-02-0 polyHema poly hydroxy ethylmethacylate having a molecular weight of greater than 1 MM Dalton mPDMS 800-1000 MW monomethacryloxypropyl terminated polydimethylsiloxane Pluronic polyoxypropylene-polyoxyethylene block co- polymer Registry No. 106392-12-5 PVP poly vinyl pyrrolidinone, wherein KD# refers to different known molecular weight distributions of poly vinyl pyrrolidinone Simma 2 3-methacryloxy-2-hydroxypropyloxy)propylbis (trimethylsiloxy)methylsilane Super-Floss anti slip/anti blocking agent, Registry No. 61790-53-2 block Tetronic alkyoxylated amine 110617-70-4 Zeospheres anti- slip/anti blocking agent block Lens Preparations Lens A Acquafilcon A lenses coated with polyhema having a molecular weight of about 1,000,000. See U.S. Pat App. No. 09/957,299, entitled “Soft Contact Lenses,” filed on Sep. 20, 2001, Example 27. The coating method is disclosed in U.S. Pat. App. No. 09/921,192, entitled “Method for Correcting Articles by Mold Transfer,” filed on Aug. 2, 2001. Lens B Contact lenses prepared as described in U.S. Pat. App. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on September 10, 2001 and its non-provisional counterpart of the same title, filed on September 6, 2002, containing by weight percent 30 % Simma 2,19% mPDMS, 31% DMA, 6% PVP (MW 360,000), 0.8% EDGMA, 0.23% CGI81, 1.5% Norbloc, 11% PVP (MW 2,500), 0.02% Blue Hema, 0-2 ac PDMS, 29% t-amyl alcohol. Lens C Contact lenses prepared as described in U.S. Pat. App. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on September 10, 2001 and its non-provisional counterpart of the same title, filed on September 6, 2002, containing by weight percent 28 % Simma 2,31% mPDMS, 23.5% DMA, 7% PVP (MW 360,000), 1.5% TEDGMA, 0.98% CGI 1850, 2.0% Norbloc, 6 HEMA, 0.02% Blue Hema. - Additives (identity and amounts listed in Table 1) were mixed with polypropylene (listed below). The material was injection molded to form the base portion of a contact lens package. The configuration of the package is as illustrated in FIG. 1 of U.S. Pat. No. 5,467,868 which is hereby incorporated by reference.
- Contact lenses made from acquafilcon A coated with polyhema, a silicone hydrogel, were added to individual polypropylene blister packs having different additives containing 950 μL of saline solution and then the blister pack was heat sealed with an flexible cover. Lenses were visually evaluated for adhesion to the package after sterilization. The flexible cover sheet was removed and the molded base is rotated or jiggled without spilling the saline solution while a contact lens is observed to determine if it is adhered to the inner surface of the molded base. Lenses that do not adhere are free floating and pass the test. If the lenses adhere to the molded base in any manner they fail the test. The addtitive, its weight percentage, the number of lenses that stuck to the package, and number of lenses that were free floating are displayed in Table 1. This example illustrates that glycerol monostearate is a superior additive.
TABLE 1 Polypropylene Additive # tested # stuck Exxon 1605 none 12 12 Exxon 1605 calcium stearate 36 36 Exxon 1605 2% glycerol monostearate 36 3 Exxon 1654 2% glycerol monostearate 84 2 Exxon 1654 none 12 12 Exxon Exxelor P1020 none 12 12 Fina EOD-0011 none 12 12 Fina EOD-0011 1% zinc stearate 12 12 Fina EOD-0011 3% zinc stearate 12 12 FINA 3924CW@ antistat 36 36 - Packages containing 2% weight percent GMS and Exxon 1605 were prepared using the method of Example 1. Contact lenses of types A, B, and C were added to individual blister packages along with 950 μL of saline solution. The filed packages were heat sealed with flexible covers and sterilized. The packaged lenses were submitted to consumers. The consumers opened the packages and evaluated the lenses for ease of removal of the lens from the package using the following criteria and grading system
-
- 1—very easy removal—Lens comes out without any problems
- 2—easy removal—a couple of attempts to remove the lenses, but overall there were no real problems in removal
- 3—moderate removal—several tries before lens comes out, neither pleased or displeased
- 4—difficult removal—many tries to remove with finger or nail—removal is frustrating
- 5—very difficult removal—many tries to remove with a finger or nail, lens damage upon removal—very unacceptable
-
FIG. 1 illustrates the testing results for a comparison of Lens A in a polypropylene package (control), Lens A in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 μm, and Len A in a package containing 2.0% GMS. This figure shows that the roughened package containing GMS has the highest consumer rating. -
FIG. 2 illustrates the testing results for a comparison of Lens B in a polypropylene package (control), Lens B in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 am, and Len B in a package containing 2.0% GMS. This figure shows that the package containing 2.0%GMS has the highest consumer rating. -
FIG. 3 illustrates the testing results for a comparison of Lens C in a polypropylene package (control), Lens C in a package containing 2.0% GMS where the package has an average surface roughness (Ra) of about 2.0 μm, and Len C in a package containing 2.0% GMS. This figure shows that the package containing 2.0% GMS has the highest consumer rating. - The testing methods and preparations of Example 1 were repeated with different additives and lens types as per Table 2. If “(UP)” appears in an entry, that bowl of the blister is shaped as in U.S. Pat. No. D 458,023. When the term “Rough Bowl” appears, the inside surface of the bowl is roughened to an Ra of 0.5 mm to 0.8 mm.
TABLE 2 Base Resin Lens Type Tested Stuck Additive Exxon 1605 PP Lens B 15 13 Calcium stearate (2%) Exxon 1605 PP Lens B 120 0 GMS (2%) Exxon 1605 PP Lens C 30 0 GMS (2%) Exxon 1605 PP Lens B 15 12 Dow Siloxane MB50-321 (10%) Exxon 1605 PP Lens B 15 13 Dow Siloxane MB50-321 (5%) Exxon 1605 PP Lens B 57 50 Ampacet 40604 99.5/.5 Erucamide Ampacet 40604 PP Lens B 15 15 Erucamide (5%) Exxon 1605 PP Lens B 15 15 Kemamide (Erucamide) (5%) Exxon 1605 PP Lens B 15 12 Superfloss anti-bock (2%) Exxon 1605 PP Lens B 15 15 Zeospheres anti-block (2%) Exxon 1605 PP Lens B 15 14 Superfloss anti-bock (2%) Oleamide (.2%) Exxon 1605 PP Lens B 14 13 Superfloss anti-bock (.2%) Oleamide (.2%) Exxon 1605 PP Lens B 15 15 Talc (5%) Exxon 1605 PP Lens B 15 13 Calcium carbonate (5%) Exxon 1605 PP Lens B 15 14 Zinc stearate (5% hand blend) Exxon 1605 PP Lens B 15 15 Zinc stearate (5% machine blend) Exxon 1605 PP Lens B 15 14 ATP (Vitamin E) (5%) Exxon 1605 PP Lens B 15 13 Licowax (1%) Exxon 1605 PP Lens B 15 14 Polyethyleneglycol monolaurate (5%) Exxon 1605 PP Lens B 15 15 Mica (5%) Exxon 1605 PP Lens B 175 8 Succinic Acid (5%) Exxon 1605 PP Lens B 15 13 Succinic Anhydride (5%) Exxon 1605 PP Lens B 118 22 Epolene E-43 (20% machine blend) Exxon 1605 PP Lens B 100 92 Epolene E-43 (20% machine blend) Exxon 1605 PP Lens B 127 52 Epolene E-43 (10% hand blend) Exxon 1605 PP Lens B 130 16 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens C 15 6 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens B 30 22 Epolene E-43 (5% machine blend) Exxon 1605 PP Lens C 15 3 Epolene E-43 (5% machine blend) Exxon 1605 PP Lens B 15 15 Atmer 163 (1%) Exxon 1605 PP Lens B 15 10 MC (5%) Exxon 1605 PP Lens B 30 2 Boric Acid (5% hand blend) Exxon 1605 PP Lens B 215 3 Boric Acid (5% machine blend) Exxon 1605 PP Lens C 15 0 Boric Acid (5% machine blend) Exxon 1605 PP Lens B 15 13 Boric Acid (3% hand blend) Exxon 1605 PP Lens B 15 15 Boric Acid (2% hand blend) Exxon 1605 PP Lens B 150 4 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens B 50 9 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens B 50 15 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens B 50 35 Epolene E-43 (10% machine blend) Exxon 1605 PP Lens B 255 6 PVP K90 (5.0%) Exxon 1605 PP Lens B 98 31 PVP K90 (2.5%) Exxon 1605 PP Lens B 98 49 PVP K90 (1.25%) Exxon 1605 PP Lens B 20 6 PVP K90 (1.0%) Exxon 1605 PP Lens B 20 10 PVP K90 (.75%) Exxon 1605 PP Lens B 20 17 PVP K90 (.5%) Exxon 1605 PP Lens C 248 5 PVP K90 (5.0%) Exxon 1605 PP Lens C 39 0 PVP K90 (10%) Blended down to 5% Exxon 1605 PP Lens C 135 42 PVP K90 (2.5%) Exxon 1605 PP Lens C 135 54 PVP K90 (1.25%) Exxon 1605 PP Lens C 70 42 PVP K90 (1.0%) Exxon 1605 PP Lens C 70 50 PVP K90 (.75%) Exxon 1605 PP Lens C 70 60 PVP K90 (.5%) Exxon 1605 PP Lens B 15 14 Nucrel 535 - 10.5% acid comonomer (2%) Exxon 1605 PP Lens B 15 15 Nucrel 925 - 15% acid comonomer (3%) Exxon 1605 PP Lens C 15 14 Nucrel 535 - 10.5% acid comonomer (2%) Exxon 1605 PP Lens C 15 14 Nucrel 925 - 15% acid comonomer (3%) Exxon 1605 PP Lens B 15 15 2% XNAP with Pluronic Exxon 1605 PP Lens C 15 14 2% XNAP with Pluronic Exxon 1605 PP Lens B 15 15 Pluronic 1% Exxon 1605 PP Lens C 15 15 Pluronic 1% Exxon 1605 PP Lens B 15 11 1% Tetronic Exxon 1605 PP Lens C 15 15 1% Tetronic Exxon 1605 PP Lens B 15 15 1% Flura Exxon 1605 PP Lens C 15 15 1% Flura Exxon 1605 PP Lens B 30 23 2% Pluronic Exxon 1605 PP Lens C 30 16 2% Pluronic Exxon 1605 PP Lens C 77 0 PVP K90 (5%) + Epolene E43 (5%) Exxon 1605 PP Lens B 50 0 PVP K90 (5%) + Epolene E43 (5%) Exxon 1605 PP Lens C 62 0 PVP K90 (5%) + Epolene E43 (1.5%) Exxon 1605 PP Lens B 50 0 PVP K90 (5%) + Epolene E43 (1.5%) Exxon 1605 PP Lens C 65 0 PVP K90 (2.5%) + Epolene E43 (1.25%) Exxon 1605 PP Lens B 50 0 PVP K90 (2.5%) + Epolene E43 (1.25%) Exxon 1605 PP Lens C 115 10 PVP K90 (1%) + Epolene E43 (1%) Exxon 1605 PP Lens B 100 11 PVP K90 (1%) + Epolene E43 (1%) Exxon 1605 PP Lens C 30 0 PVP K29/31 (5%) Exxon 1605 PP Lens C 30 0 PVP K60 (5%) Exxon 1605 PP Lens B 50 0 PVP K90 (1%) + Rough Bowl (UP) Exxon 1605 PP Lens C 50 0 PVP K90 (1%) + Rough Bowl (UP) Exxon 1605 PP Lens B 170 0 Epolene E43 (1%) + Rough Bowl Exxon 1605 PP Lens C 200 0 Epolene E43 (1%) + Rough Bowl
Claims (48)
1. A package for storing medical devices in a solution comprising a molded base wherein the molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema.
2. The package of claim 1 wherein the additive is selected from the group consisting of succinic acid, glycerol monostearate, PVP, and PVP/maleic anhydride.
3. The package of claim 1 wherein the additive is glycerol monostearate.
4. The package of claim 3 wherein glycerol monostearate is present at a concentration of greater than about 0.5 weight percent to about 5 weight percent.
5. The package of claim 3 wherein glycerol monostearate is present at a concentration of about 2 percent.
6. The package of claim 1 wherein the additive is PVP KD90.
7. The package of claim 6 wherein the PVP concentration is about 1% to about 5%.
8. The package of claim 6 wherein the PVP concentration is about 1.0%.
9. The package of claim 1 wherein the additive is PVP KD90/maleic anhydride.
10. The package of claim 9 wherein the PVP KD90/maleic anhydride concentration is about 1/1% to about 5/5%.
11. The package of claim 1 wherein the medical device is a contact lens which comprises balafilcon A, lotrafilcon A, galyfilcon, senofilcon, or lenses disclosed in U.S. patent application Ser. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on Sep. 10, 2001 and its non-provisional counterpart of the same title, filed on Sep. 6, 2002.
12. The package of claim 11 wherein the contact lens comprises Simma 2 and mPDMS.
13. The package of claim 11 wherein the contact lens comprises Simma 2
14. The package of claim 1 wherein the molded base comprises polypropylene.
15. The package of claim 1 further comprising a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm.
16. The package of claim 15 wherein the inner surface has an average roughness of about 1.8 μm to about 4.5 μm.
17. The package of claim 15 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm
18. The package of claim 15 wherein the inner surface has an average roughness of about 0.5 μm to about 0.8 μm.
19. The package of claim 1 further comprising a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm and the additive is glycerol monostearate or PVP.
20. The package of claim 19 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of PVP is about 1%.
21. The package of claim 19 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of PVP is about 1%.
22. The package of claim 1 further comprising a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm and the additive is maleic anhydride or PVP/maleic anhydride.
23. The package of claim 22 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of PVP/maleic anhydride is about 1%.
24. The package of claim 22 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of PVP/maleic anhydride is about 1%.
25. The package of claim 22 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of maleic anhydride is about 1%.
26. The package of claim 22 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of maleic anhydride is about 1%.
27. A method of reducing the adherence of a medical device to its packaging, comprising storing said medical device in a solution in a package comprising a molded base wherein said molded base comprises an additive, provided that the medical device is not a contact lens consisting of acqualfilcon A coated with polyHema.
28. The method of claim 27 wherein additive is selected from the group consisting of succinic acid, glycerol monostearate, and PVP.
29. The method of claim 27 wherein the additive is glycerol monostearate.
30. The method of claim 27 wherein glycerol monostearate is present at a concentration of greater than about 0.25 weight percent to about 5 weight percent.
31. The method of claim 27 wherein glycerol monostearate is present at a concentration of about 2 percent.
32. The method of claim 27 wherein the additive is PVP KD90.
33. The method of claim 27 wherein the PVP is present at about 1% to about 5%.
34. The method of claim 27 wherein the contact lens comprises balafilcon A, lotrafilcon A, or lenses disclosed in U.S. patent application Ser. No. 60/318,536, entitled Biomedical Devices Containing Internal wetting Agents,” filed on Sep. 10, 2001 and its non-provisional counterpart of the same title, filed on Sep. 6, 2002.
35. The method of claim 27 wherein the contact lens comprises Simma 2
36. The method of claim 27 wherein the molded base comprises polypropylene.
37. The method of claim 27 further comprising a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm and the additive is glycerol monostearate or PVP.
38. The method of claim 37 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of PVP is about 1%.
39. The method of claim 37 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of PVP is about 1%.
40. The method of claim 27 further comprising a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm and the additive is maleic anhydride or PVP/maleic anhydride.
41. The method of claim 40 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of PVP/maleic anhydride is about 1%.
42. The method of claim 40 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of PVP/maleic anhydride is about 1%.
43. The method of claim 40 wherein the average roughness of the inner surface is about 0.5 μm to about 0.8 μm and the concentration of maleic anhydride is about 1%.
44. The method of claim 40 wherein the inner surface has an average roughness of about 1.9 μm to about 2.1 μm and the concentration of maleic anhydride is about 1%.
45. A method of hydrating a contact lens comprising, consisting essentially of, or consisting of hydrating said lens in a molded base wherein said molded base comprises an additive.
46. The method of claim 45 wherein the additive is selected from the group consisting of succinic acid, glycerol monostearate, PVP, and PVP/maleic anhydride.
47. The method of claim 46 wherein the additives are present at a concentration of greater than about 0.25 weight percent to about 5 weight percent.
48. The method of claim 45 wherein the molded base further comprises a cavity formed in said molded base wherein said cavity comprises an inner surface, wherein said inner surface has an average roughness of about 0.5 μm to about 20 μm and the additive is maleic anhydride or PVP/maleic anhydride.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/731,258 US20050006255A1 (en) | 2002-12-23 | 2003-12-09 | Contact lens packages containing additives |
US12/342,506 US20090165427A1 (en) | 2002-12-23 | 2008-12-23 | Contact lens packages containing additives |
US14/594,558 US20150121809A1 (en) | 2002-12-23 | 2015-01-12 | Contact lens packages containing additives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43610902P | 2002-12-23 | 2002-12-23 | |
US10/731,258 US20050006255A1 (en) | 2002-12-23 | 2003-12-09 | Contact lens packages containing additives |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/342,506 Division US20090165427A1 (en) | 2002-12-23 | 2008-12-23 | Contact lens packages containing additives |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050006255A1 true US20050006255A1 (en) | 2005-01-13 |
Family
ID=32713054
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/731,258 Abandoned US20050006255A1 (en) | 2002-12-23 | 2003-12-09 | Contact lens packages containing additives |
US12/342,506 Abandoned US20090165427A1 (en) | 2002-12-23 | 2008-12-23 | Contact lens packages containing additives |
US14/594,558 Abandoned US20150121809A1 (en) | 2002-12-23 | 2015-01-12 | Contact lens packages containing additives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/342,506 Abandoned US20090165427A1 (en) | 2002-12-23 | 2008-12-23 | Contact lens packages containing additives |
US14/594,558 Abandoned US20150121809A1 (en) | 2002-12-23 | 2015-01-12 | Contact lens packages containing additives |
Country Status (13)
Country | Link |
---|---|
US (3) | US20050006255A1 (en) |
EP (10) | EP2283876A1 (en) |
JP (1) | JP4776926B2 (en) |
KR (1) | KR101229813B1 (en) |
CN (1) | CN100384484C (en) |
AR (1) | AR043320A1 (en) |
AU (2) | AU2003296355B2 (en) |
BR (1) | BR0317631B1 (en) |
CA (3) | CA2510567C (en) |
DE (1) | DE60331170D1 (en) |
HK (4) | HK1080399A1 (en) |
TW (1) | TWI350187B (en) |
WO (1) | WO2004060099A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080015315A1 (en) * | 2006-07-12 | 2008-01-17 | Frank Chang | Novel Polymers |
US20080143958A1 (en) * | 2006-12-13 | 2008-06-19 | Arturo Norberto Medina | Production of ophthalmic devices based on photo-induced step growth polymerization |
US20080174035A1 (en) * | 2006-06-08 | 2008-07-24 | Lynn Cook Winterton | Silicone hydrogel contact lenses |
US20090059165A1 (en) * | 2007-08-31 | 2009-03-05 | John Dallas Pruitt | Contact lens products |
US20090057164A1 (en) * | 2007-08-31 | 2009-03-05 | Kasey Jon Minick | Contact lens packaging solutions |
US20090086160A1 (en) * | 2007-09-28 | 2009-04-02 | Enns John B | Methods of sterilizing ophthalmic lenses |
US8051978B2 (en) | 2008-10-21 | 2011-11-08 | Menicon Co., Ltd. | Contact lens storage container |
US9829723B2 (en) | 2015-12-03 | 2017-11-28 | Novartis Ag | Contact lens packaging solutions |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050205451A1 (en) * | 2004-03-18 | 2005-09-22 | Brown-Skrobot Susan K | Contact lens packages |
US20060051454A1 (en) * | 2004-08-26 | 2006-03-09 | Ansell Scott F | Molds for producing ophthalmic lenses |
US7426993B2 (en) | 2005-08-09 | 2008-09-23 | Coopervision International Holding Company, Lp | Contact lens package |
US8414804B2 (en) | 2006-03-23 | 2013-04-09 | Johnson & Johnson Vision Care, Inc. | Process for making ophthalmic lenses |
US7540609B2 (en) | 2006-06-15 | 2009-06-02 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US8231218B2 (en) | 2006-06-15 | 2012-07-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US7572841B2 (en) | 2006-06-15 | 2009-08-11 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
GB2493017B (en) * | 2011-07-19 | 2016-08-03 | Carl Zeiss Meditec Sas | Cassette for an intraocular lens and injector device for an intraocular lens |
CN102502091A (en) * | 2011-10-27 | 2012-06-20 | 广州科甫眼镜有限公司 | Storing and placing appliance of transparent contact lens with magnifying function and preparation method thereof |
Citations (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US69896A (en) * | 1867-10-15 | Hakey bitter | ||
US3394717A (en) * | 1966-09-20 | 1968-07-30 | Richard G. Hollinger | Contact lens container |
US4100309A (en) * | 1977-08-08 | 1978-07-11 | Biosearch Medical Products, Inc. | Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same |
US4129211A (en) * | 1976-09-07 | 1978-12-12 | Monsanto Company | Wafer packaging system |
US4159292A (en) * | 1977-05-25 | 1979-06-26 | Neefe Optical Lab. Inc. | Method of controlling the release of a cast plastic lens from a resinous lens mold |
US4691820A (en) * | 1985-11-18 | 1987-09-08 | Vistakon, Inc. | Package for hydrophilic contact lens |
US4858754A (en) * | 1988-06-07 | 1989-08-22 | Ryder International Corporation | Molding apparatus and construction of contact lens case |
US4949959A (en) * | 1989-10-10 | 1990-08-21 | Stevens William E | Barbell assist device |
US4981657A (en) * | 1988-09-09 | 1991-01-01 | Ryder International Corporation | Contact lens case with raised, protective ribs |
US5054610A (en) * | 1989-05-31 | 1991-10-08 | Ciba-Geigy Corporation | Disposable single-use contact lens conditioning package |
US5084393A (en) * | 1988-09-01 | 1992-01-28 | Alena Rogalsky | Container for a biological culture |
US5130011A (en) * | 1991-09-19 | 1992-07-14 | Sage Jr James R | Contact lens holder |
US5337888A (en) * | 1993-09-01 | 1994-08-16 | Morrison Robert J | Contact lens case |
US5375698A (en) * | 1993-05-07 | 1994-12-27 | Allergan, Inc. | Prefilled, resealable contact lens container |
US5409104A (en) * | 1994-06-01 | 1995-04-25 | Ciba-Geigy Corporation | Contact lens package having improved access features |
US5467868A (en) * | 1992-12-21 | 1995-11-21 | Johnson & Johnson Vision Products, Inc. | Ophthalmic lens package |
US5515964A (en) * | 1995-04-13 | 1996-05-14 | Bauman; Robert C. | Contact lens package with lens retaining recess |
US5573108A (en) * | 1988-11-02 | 1996-11-12 | British Technology Group Ltd. | Disposable contact lens package |
US5609246A (en) * | 1994-05-04 | 1997-03-11 | Ciba Geigy Corporation | Blister pack for an optical lens |
US5695049A (en) * | 1996-10-10 | 1997-12-09 | Johnson & Johnson Vision Products, Inc. | Contact lens package with insertion feature |
US5697495A (en) * | 1993-11-02 | 1997-12-16 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5704468A (en) * | 1995-09-29 | 1998-01-06 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5705254A (en) * | 1994-03-10 | 1998-01-06 | Canon Kabushiki Kaisha | Plastic molded article with a finished surface appearance |
US5710302A (en) * | 1995-12-07 | 1998-01-20 | Bausch & Lomb Incorporated | Monomeric units useful for reducing the modules of silicone hydrogels |
US5711416A (en) * | 1994-06-15 | 1998-01-27 | Bauman; Robert C. | Disposable contact lens storage container with concave storage recess |
US5722536A (en) * | 1996-02-08 | 1998-03-03 | Bausch & Lomb Incorporated | Disposable contact lens package with snap-together feature |
US5760100A (en) * | 1994-09-06 | 1998-06-02 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5776999A (en) * | 1994-09-06 | 1998-07-07 | Ciba Vision Corporation | Methods of using and screening extended wear ophthalmic lenses |
US5823327A (en) * | 1993-11-02 | 1998-10-20 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5972292A (en) * | 1997-04-16 | 1999-10-26 | Bausch & Lomb Incorporated | Sealing and venting system for oxidative disinfection of contact lenses |
US5998498A (en) * | 1998-03-02 | 1999-12-07 | Johnson & Johnson Vision Products, Inc. | Soft contact lenses |
US6029808A (en) * | 1999-01-29 | 2000-02-29 | Johnson & Johnson Vision Products, Inc. | Primary package for contact lens |
US6042230A (en) * | 1998-12-14 | 2000-03-28 | Johnson & Johnson Vision Products, Inc. | Markings for contact lenses |
US6044966A (en) * | 1997-06-25 | 2000-04-04 | Wohlk Contact-Linsen Gmbh | Ready-for-sale container for transporting contact lenses, and contact lens provided for this container |
US6050398A (en) * | 1998-11-25 | 2000-04-18 | Novartis, Ag | Contact lens storage container |
US6082533A (en) * | 1998-12-15 | 2000-07-04 | Bausch & Lomb Incorporated | Contact lens package |
US6087415A (en) * | 1998-06-11 | 2000-07-11 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with hydrophilic coatings |
US6244430B1 (en) * | 1998-10-26 | 2001-06-12 | Aaron T. Travis | Easily transported contact lens care kit |
US6286666B1 (en) * | 1997-07-30 | 2001-09-11 | Stefen Umdasch Design Kg | Container for the storage of contact lenses |
US20020046958A1 (en) * | 2000-09-01 | 2002-04-25 | Lipscomb Lance Kyle | Textured contact lens package |
US6398018B1 (en) * | 1997-07-30 | 2002-06-04 | Ocular Sciences, Inc. | Container |
USD458023S1 (en) * | 1999-10-13 | 2002-06-04 | Johnson & Johnson Vision Care, Inc. | Contact lens container |
US6401915B1 (en) * | 1997-10-14 | 2002-06-11 | Thomas Faxe | Package with an applicator for a contact lens |
US6474465B1 (en) * | 1999-11-19 | 2002-11-05 | Novartis Ag | Blister package |
US6532431B1 (en) * | 2002-07-12 | 2003-03-11 | Lsi Logic Corporation | Ratio testing |
US20030052424A1 (en) * | 2001-08-02 | 2003-03-20 | Turner David C. | Method for coating articles by mold transfer |
US20040004008A1 (en) * | 2002-06-26 | 2004-01-08 | Peck James M. | Contact lens packages |
US6822016B2 (en) * | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6943203B2 (en) * | 1998-03-02 | 2005-09-13 | Johnson & Johnson Vision Care, Inc. | Soft contact lenses |
US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US7225919B2 (en) * | 2001-11-07 | 2007-06-05 | Provis Limited | Packaging for contact lenses |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5293398A (en) * | 1976-02-02 | 1977-08-05 | Toa Medical Electronics | Preparing process of beaker for dilution of blood sample |
GB2078760B (en) * | 1980-06-19 | 1984-06-27 | Metal Box Co Ltd | Processable plastics containers |
US4363891A (en) * | 1981-05-14 | 1982-12-14 | Glyco Inc. | Glyceryl monostearate plastic lubricants |
US4481624A (en) * | 1982-06-24 | 1984-11-06 | At&T Bell Laboratories | Linear time division multiplexed conferencer |
US4481324A (en) * | 1983-02-25 | 1984-11-06 | Glyco Inc. | Polyglycerol plastic lubricants |
ES2096846T3 (en) * | 1988-11-02 | 1997-03-16 | British Tech Group | MOLDING AND CONTAINER CONTACT LENSES. |
US5115056A (en) | 1989-06-20 | 1992-05-19 | Ciba-Geigy Corporation | Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof |
JPH04183739A (en) * | 1990-11-19 | 1992-06-30 | Mitsubishi Petrochem Co Ltd | Propylene copolymer resin dispersion |
US5264161A (en) * | 1991-09-05 | 1993-11-23 | Bausch & Lomb Incorporated | Method of using surfactants as contact lens processing aids |
EP1163914B1 (en) * | 1993-01-15 | 2006-03-29 | PANKOW, Mark L. | Contact lens treatment apparatus |
US5374662A (en) | 1993-03-15 | 1994-12-20 | Bausch & Lomb Incorporated | Fumarate and fumaramide siloxane hydrogel compositions |
AU6638694A (en) * | 1993-04-21 | 1994-11-08 | Allergan, Inc. | Contact lens containers and methods of using |
JP3219348B2 (en) * | 1994-03-31 | 2001-10-15 | 雪印乳業株式会社 | Composite food in container, method for producing the same, and container used therefor |
TW349967B (en) * | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
US5849209A (en) * | 1995-03-31 | 1998-12-15 | Johnson & Johnson Vision Products, Inc. | Mold material made with additives |
JPH105311A (en) * | 1996-06-25 | 1998-01-13 | Terumo Corp | Medical resealable member and plug for medical container |
JPH10195257A (en) * | 1997-01-10 | 1998-07-28 | Asahi Chem Ind Co Ltd | Polyethylene resin composition for blow molding and container |
JP2000016905A (en) | 1998-07-01 | 2000-01-18 | Tokuriki Kagaku Kenkyusho:Kk | Antibacterial-fungal agent and antibacterial-fungal material |
DE69910950T2 (en) * | 1998-11-19 | 2004-07-15 | Mitsui Chemicals, Inc. | Resin compositions based on polyolefins and products made therefrom |
CA2299691C (en) * | 1999-03-01 | 2011-07-12 | Johnson & Johnson Vision Care, Inc. | Package for medical device |
DE19958007A1 (en) * | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Injection molding process for (meth) acrylate copolymers with tertiary ammonium groups |
US6280530B1 (en) * | 2000-01-28 | 2001-08-28 | Isoclear, Inc. | Contact lens treatment apparatus and method |
KR100757968B1 (en) * | 2000-04-18 | 2007-09-11 | 도소 가부시키가이샤 | A method for producing a composition of thermoplastic resin |
US6634748B1 (en) * | 2000-11-15 | 2003-10-21 | Johnson & Johnson Vision Care, Inc. | Methods of stabilizing silicone hydrogels against hydrolytic degradation |
US6867172B2 (en) * | 2000-12-07 | 2005-03-15 | Johnson & Johnson Vision Care, Inc. | Methods of inhibiting the adherence of lenses to their packaging |
US20020197299A1 (en) * | 2000-12-21 | 2002-12-26 | Vanderlaan Douglas G. | Antimicrobial contact lenses containing activated silver and methods for their production |
KR100455662B1 (en) * | 2002-03-14 | 2004-11-06 | 학교법인 포항공과대학교 | Aminocyclopentadienyl ruthenium complexes and preparation thereof |
-
2003
- 2003-12-09 EP EP20100181102 patent/EP2283876A1/en not_active Withdrawn
- 2003-12-09 CA CA2510567A patent/CA2510567C/en not_active Expired - Fee Related
- 2003-12-09 JP JP2004565266A patent/JP4776926B2/en not_active Expired - Fee Related
- 2003-12-09 BR BRPI0317631-2B1A patent/BR0317631B1/en not_active IP Right Cessation
- 2003-12-09 AU AU2003296355A patent/AU2003296355B2/en not_active Ceased
- 2003-12-09 DE DE60331170T patent/DE60331170D1/en not_active Expired - Lifetime
- 2003-12-09 EP EP20100181092 patent/EP2281584A1/en not_active Withdrawn
- 2003-12-09 EP EP20100181146 patent/EP2281585A1/en not_active Withdrawn
- 2003-12-09 CA CA 2737309 patent/CA2737309A1/en not_active Abandoned
- 2003-12-09 US US10/731,258 patent/US20050006255A1/en not_active Abandoned
- 2003-12-09 WO PCT/US2003/039017 patent/WO2004060099A2/en active Application Filing
- 2003-12-09 EP EP10181065.3A patent/EP2281583B1/en not_active Expired - Fee Related
- 2003-12-09 KR KR1020057011801A patent/KR101229813B1/en active IP Right Grant
- 2003-12-09 EP EP20100181163 patent/EP2283879A1/en not_active Withdrawn
- 2003-12-09 EP EP20100181172 patent/EP2281586A1/en not_active Withdrawn
- 2003-12-09 CA CA2809146A patent/CA2809146C/en not_active Expired - Fee Related
- 2003-12-09 EP EP10181121.4A patent/EP2283877B1/en not_active Expired - Fee Related
- 2003-12-09 EP EP10181154.5A patent/EP2283878B1/en not_active Expired - Fee Related
- 2003-12-09 EP EP03814670A patent/EP1575625B1/en not_active Revoked
- 2003-12-09 CN CNB2003801074017A patent/CN100384484C/en not_active Expired - Fee Related
- 2003-12-09 EP EP20060076076 patent/EP1704875B1/en not_active Expired - Fee Related
- 2003-12-22 TW TW092136345A patent/TWI350187B/en not_active IP Right Cessation
- 2003-12-23 AR ARP030104826 patent/AR043320A1/en not_active Application Discontinuation
-
2006
- 2006-01-10 HK HK06100398.2A patent/HK1080399A1/en not_active IP Right Cessation
-
2008
- 2008-12-23 US US12/342,506 patent/US20090165427A1/en not_active Abandoned
-
2010
- 2010-08-10 AU AU2010212246A patent/AU2010212246B2/en not_active Ceased
-
2011
- 2011-06-29 HK HK11106692.5A patent/HK1152663A1/en not_active IP Right Cessation
- 2011-07-27 HK HK11107823.5A patent/HK1153685A1/en not_active IP Right Cessation
- 2011-07-27 HK HK11107824.4A patent/HK1153686A1/en not_active IP Right Cessation
-
2015
- 2015-01-12 US US14/594,558 patent/US20150121809A1/en not_active Abandoned
Patent Citations (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US69896A (en) * | 1867-10-15 | Hakey bitter | ||
US3394717A (en) * | 1966-09-20 | 1968-07-30 | Richard G. Hollinger | Contact lens container |
US4129211A (en) * | 1976-09-07 | 1978-12-12 | Monsanto Company | Wafer packaging system |
US4159292A (en) * | 1977-05-25 | 1979-06-26 | Neefe Optical Lab. Inc. | Method of controlling the release of a cast plastic lens from a resinous lens mold |
US4100309A (en) * | 1977-08-08 | 1978-07-11 | Biosearch Medical Products, Inc. | Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same |
US4691820A (en) * | 1985-11-18 | 1987-09-08 | Vistakon, Inc. | Package for hydrophilic contact lens |
US4858754A (en) * | 1988-06-07 | 1989-08-22 | Ryder International Corporation | Molding apparatus and construction of contact lens case |
US5084393A (en) * | 1988-09-01 | 1992-01-28 | Alena Rogalsky | Container for a biological culture |
US4981657A (en) * | 1988-09-09 | 1991-01-01 | Ryder International Corporation | Contact lens case with raised, protective ribs |
US5573108A (en) * | 1988-11-02 | 1996-11-12 | British Technology Group Ltd. | Disposable contact lens package |
US5054610A (en) * | 1989-05-31 | 1991-10-08 | Ciba-Geigy Corporation | Disposable single-use contact lens conditioning package |
US4949959A (en) * | 1989-10-10 | 1990-08-21 | Stevens William E | Barbell assist device |
US5130011A (en) * | 1991-09-19 | 1992-07-14 | Sage Jr James R | Contact lens holder |
US5467868A (en) * | 1992-12-21 | 1995-11-21 | Johnson & Johnson Vision Products, Inc. | Ophthalmic lens package |
US5375698A (en) * | 1993-05-07 | 1994-12-27 | Allergan, Inc. | Prefilled, resealable contact lens container |
US5337888A (en) * | 1993-09-01 | 1994-08-16 | Morrison Robert J | Contact lens case |
US5983608A (en) * | 1993-11-02 | 1999-11-16 | Johnson & Johnson Vision Products, Inc. | Packaging method for contact lenses |
US5697495A (en) * | 1993-11-02 | 1997-12-16 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5823327A (en) * | 1993-11-02 | 1998-10-20 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5705254A (en) * | 1994-03-10 | 1998-01-06 | Canon Kabushiki Kaisha | Plastic molded article with a finished surface appearance |
US5609246A (en) * | 1994-05-04 | 1997-03-11 | Ciba Geigy Corporation | Blister pack for an optical lens |
US5409104A (en) * | 1994-06-01 | 1995-04-25 | Ciba-Geigy Corporation | Contact lens package having improved access features |
US5711416A (en) * | 1994-06-15 | 1998-01-27 | Bauman; Robert C. | Disposable contact lens storage container with concave storage recess |
US5849811A (en) * | 1994-09-06 | 1998-12-15 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
US5776999B1 (en) * | 1994-09-06 | 2000-11-21 | Ciba Vision Corp | Methods of using and screening extended wear opthalmic lenses |
US5760100A (en) * | 1994-09-06 | 1998-06-02 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5776999A (en) * | 1994-09-06 | 1998-07-07 | Ciba Vision Corporation | Methods of using and screening extended wear ophthalmic lenses |
US5789461A (en) * | 1994-09-06 | 1998-08-04 | Ciba Vision Corporation | Methods of forming an extended wear ophthalmic lens having a hydrophilic surface |
US5789461B1 (en) * | 1994-09-06 | 2000-11-21 | Ciba Vision Corp | Methods of forming an extended wear ophthalmic lens having a hydrophilic surface |
US5849811B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corporatin | Extended wear ophthalmic lens |
US5965631A (en) * | 1994-09-06 | 1999-10-12 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5515964A (en) * | 1995-04-13 | 1996-05-14 | Bauman; Robert C. | Contact lens package with lens retaining recess |
US5704468A (en) * | 1995-09-29 | 1998-01-06 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement for contact lenses |
US5710302A (en) * | 1995-12-07 | 1998-01-20 | Bausch & Lomb Incorporated | Monomeric units useful for reducing the modules of silicone hydrogels |
US5722536A (en) * | 1996-02-08 | 1998-03-03 | Bausch & Lomb Incorporated | Disposable contact lens package with snap-together feature |
US5695049A (en) * | 1996-10-10 | 1997-12-09 | Johnson & Johnson Vision Products, Inc. | Contact lens package with insertion feature |
US5972292A (en) * | 1997-04-16 | 1999-10-26 | Bausch & Lomb Incorporated | Sealing and venting system for oxidative disinfection of contact lenses |
US6044966A (en) * | 1997-06-25 | 2000-04-04 | Wohlk Contact-Linsen Gmbh | Ready-for-sale container for transporting contact lenses, and contact lens provided for this container |
US6286666B1 (en) * | 1997-07-30 | 2001-09-11 | Stefen Umdasch Design Kg | Container for the storage of contact lenses |
US6398018B1 (en) * | 1997-07-30 | 2002-06-04 | Ocular Sciences, Inc. | Container |
US6401915B1 (en) * | 1997-10-14 | 2002-06-11 | Thomas Faxe | Package with an applicator for a contact lens |
US5998498A (en) * | 1998-03-02 | 1999-12-07 | Johnson & Johnson Vision Products, Inc. | Soft contact lenses |
US6943203B2 (en) * | 1998-03-02 | 2005-09-13 | Johnson & Johnson Vision Care, Inc. | Soft contact lenses |
US6087415A (en) * | 1998-06-11 | 2000-07-11 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with hydrophilic coatings |
US6318548B1 (en) * | 1998-10-26 | 2001-11-20 | Aaron T. Travis | Easily transported contact lens care kit |
US6244430B1 (en) * | 1998-10-26 | 2001-06-12 | Aaron T. Travis | Easily transported contact lens care kit |
US6050398A (en) * | 1998-11-25 | 2000-04-18 | Novartis, Ag | Contact lens storage container |
US6042230A (en) * | 1998-12-14 | 2000-03-28 | Johnson & Johnson Vision Products, Inc. | Markings for contact lenses |
US6082533A (en) * | 1998-12-15 | 2000-07-04 | Bausch & Lomb Incorporated | Contact lens package |
US6029808A (en) * | 1999-01-29 | 2000-02-29 | Johnson & Johnson Vision Products, Inc. | Primary package for contact lens |
USD458023S1 (en) * | 1999-10-13 | 2002-06-04 | Johnson & Johnson Vision Care, Inc. | Contact lens container |
US6474465B1 (en) * | 1999-11-19 | 2002-11-05 | Novartis Ag | Blister package |
US20020046958A1 (en) * | 2000-09-01 | 2002-04-25 | Lipscomb Lance Kyle | Textured contact lens package |
US7374037B2 (en) * | 2000-09-01 | 2008-05-20 | Novartis Ag | Textured contact lens package |
US20030052424A1 (en) * | 2001-08-02 | 2003-03-20 | Turner David C. | Method for coating articles by mold transfer |
US6822016B2 (en) * | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US7225919B2 (en) * | 2001-11-07 | 2007-06-05 | Provis Limited | Packaging for contact lenses |
US20040004008A1 (en) * | 2002-06-26 | 2004-01-08 | Peck James M. | Contact lens packages |
US6532431B1 (en) * | 2002-07-12 | 2003-03-11 | Lsi Logic Corporation | Ratio testing |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080174035A1 (en) * | 2006-06-08 | 2008-07-24 | Lynn Cook Winterton | Silicone hydrogel contact lenses |
US7858000B2 (en) | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
US8703875B2 (en) | 2006-07-12 | 2014-04-22 | Novartis Ag | Polymers |
US20080015315A1 (en) * | 2006-07-12 | 2008-01-17 | Frank Chang | Novel Polymers |
US8404783B2 (en) | 2006-07-12 | 2013-03-26 | Novartis Ag | Polymers |
US8357771B2 (en) | 2006-12-13 | 2013-01-22 | Novartis Ag | Production of ophthalmic devices based on photo-induced step growth polymerization |
US20080143958A1 (en) * | 2006-12-13 | 2008-06-19 | Arturo Norberto Medina | Production of ophthalmic devices based on photo-induced step growth polymerization |
US8609745B2 (en) | 2006-12-13 | 2013-12-17 | Novartis Ag | Production of ophthalmic devices based on photo-induced step growth polymerization |
US8003710B2 (en) | 2006-12-13 | 2011-08-23 | Novartis Ag | Production of ophthalmic devices based on photo-induced step growth polymerization |
US8647658B2 (en) | 2007-08-31 | 2014-02-11 | Novartis Ag | Contact lens products |
US20090057164A1 (en) * | 2007-08-31 | 2009-03-05 | Kasey Jon Minick | Contact lens packaging solutions |
US8689971B2 (en) | 2007-08-31 | 2014-04-08 | Novartis Ag | Contact lens packaging solutions |
US20090059165A1 (en) * | 2007-08-31 | 2009-03-05 | John Dallas Pruitt | Contact lens products |
US9162784B2 (en) | 2007-08-31 | 2015-10-20 | Novartis Ag | Contact lens packaging solutions |
US9348061B2 (en) | 2007-08-31 | 2016-05-24 | Novartis Ag | Contact lens products |
US20090086160A1 (en) * | 2007-09-28 | 2009-04-02 | Enns John B | Methods of sterilizing ophthalmic lenses |
US8051978B2 (en) | 2008-10-21 | 2011-11-08 | Menicon Co., Ltd. | Contact lens storage container |
US9829723B2 (en) | 2015-12-03 | 2017-11-28 | Novartis Ag | Contact lens packaging solutions |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150121809A1 (en) | Contact lens packages containing additives | |
US8490782B2 (en) | Packaging solutions | |
EP1667911B1 (en) | Method and container for sterilizing and storing soft contact lenses | |
EP1441962A2 (en) | Packaging for contact lenses | |
WO2023105470A1 (en) | Slotted contact lens packages and methods of handling | |
US20240099435A1 (en) | Flat contact lens packages and methods of handling | |
TW202327482A (en) | Touchless contact lens packages and methods of handling | |
WO2023111838A1 (en) | Contact lens packages with sliding or tilting lens transfer and methods of handling | |
WO2023111943A1 (en) | Contact lens packages having a pivot mechanism and methods of handling | |
WO2023111851A1 (en) | Solutionless contact lens packages and methods of manufacture | |
WO2009067313A1 (en) | Packaging solutions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |